Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2003
by Facet Biotech.
Recruitment status was Active, not recruiting
Study NCT00032279 Information provided by Facet Biotech
First Received on March 15, 2002. Last Updated on June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Graft-vs-Host Disease
Additional conditions recognized in this trial
Graft vs Host Disease
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
Visilizumab
Additional drug interventions recognized in this trial
Glucocorticoids
More general drug interventions related to this trial
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Fred Hutchinson Cancer Research Center
Facet Biotech
Back to top of Main Content